Bausch Health — Third Quarter 2026 Earnings Summary

Bausch Health reported third-quarter 2026 consolidated revenues of $2.94 billion, representing a 10% increase on a reported basis and 8% on an organic basis compared to the prior year. The company achieved GAAP net income attributable to Bausch Health of $436 million and consolidated adjusted EBITDA of $1.305 billion, marking a 32% year-over-year growth. Excluding Bausch + Lomb, the company delivered its fourteenth consecutive quarter of revenue and adjusted EBITDA growth, with adjusted EBITDA exceeding $1 billion for the first time. Consequently, Bausch Health raised its full-year 2026 guidance for revenue, adjusted EBITDA, and adjusted cash flows from operations.